ArticleJapanese journal of radiology2025
External validation of the performance of commercially available deep-learning-based lung nodule detection on low-dose CT images for lung cancer screening in Japan.
Article in Japanese journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Diagnostic performance of commercial AI systems versus participating radiologists for pulmonary nodule detection in routine clinical practice.Japanese journal of radiology · 2026Article
- Artificial intelligence-based lung nodule detection for pulmonary arteriovenous fistulas on chest computed tomography.World journal of radiology · 2026Article
- Disparities in Lung Cancer Health Outcomes and Access to Lung Cancer Screening Between Rural and Urban Areas in the U.S.Cancers · 2026Review
- Performance of a deep-learning-based lung nodule detection system using 0.25-mm thick ultra-high-resolution CT images.Japanese journal of radiology · 2025Article
- Ultra-high-resolution imaging of intracranial flow diverters with photon counting CT: A comparative phantom study with flat-panel CT.Scientific reports · 2025Article
- Progress and challenges of artificial intelligence in lung cancer clinical translation.NPJ precision oncology · 2025Review
- Deep Learning in Thoracic Oncology: Meta-Analytical Insights into Lung Nodule Early-Detection Technologies.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeArtificial intelligence (AI) algorithms for lung nodule detection have been developed to assist radiologists. However, external validation of its performance on low-dose CT (LDCT) images is insufficient. We examined the performance of the commercially available deep-learning-based lung nodule detection (DL-LND) using LDCT images at Japanese lung cancer screening (LCS). MATERIALS AND
methodsIncluded were 43 patients with suspected lung cancer on LDCT images and pathologically confirmed lung cancer. The reference standard for nodules whose diameter exceeded 4 mm was set by a radiologist who referred to the reports of two other radiologists reading the LDCT images. After we applied commercially available DL-LND to the LDCT images, the radiologist reviewed all nodules detected by DL-LND. When he failed to identify an existing nodule, it was also included in the reference standard. To validate the performance of DL-LND, the sensitivity for lung nodules and lung cancer, the positive-predictive value (PPV) for lung nodules, and the mean number of false-positive (FP) nodules per CT scan were recorded.
resultsThe radiologist detected 97 nodules including 43 lung cancers and missed 3 solid nodules detected by DL-LND. A total of 100 nodules was included in the reference standard. DL-LND detected 396 nodules including 40 lung cancers. The sensitivity for the 100 nodules was 96.0%; the PPV was 24.2% (96/396). The mean number of FP nodules per CT scan was 7.0; sensitivity for lung cancer was 93.0% (40/43). DL-LND missed three lung cancers; 2 of these were atypical pulmonary cysts.
conclusionWe externally verified that the sensitivity for lung nodules and lung cancer by DL-LND was very high. However, its low PPV and the increased FP nodules remains a serious drawback of DL-LND.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.